Search: 2017 EU Meeting Faculty
Results 1 - 7 of 7

Susan Scott

Director
Scott Pharma Solutions Ltd


Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (2/2009)

Bio: Since 2014, Susan Scott has been a director of Scott Pharma Solutions Ltd, providing consultancy in the arena of disclosure of clinical trials as scientific publications and on clinical trial registries. For a decade before that, she was the Director of Publications & Communications for Ipsen, a mid-size European pharmaceutical company. Responsible for establishing and building their global publication management function, she also created and led the group managing clinical trial registration and results posting. With a PhD in biochemistry from University of London, she previously worked for GSK as a project leader in neurology having gained extensive experience in clinical study management in several therapeutic areas for its heritage companies. She is accredited with the Certificate of Medical Publication Professionals (CMPP), and is now on the ISMPP Recertification committee. She has presented or chaired sessions at numerous ISMPP, DIA and CBI Publication conferences in Europe and the US.

Gavin Sharrock

Business Development Director, Society Services
Wiley
-OX136AN


Type of Company:
Publisher
Professional Degrees: CMPP
CMPP Certified: (9/2015)

Bio: Gavin Sharrock is Business Development Director, Society Services Team, Wiley. Gavin started his career at Wiley (formerly Blackwell Publishing) as a Production Editor in Content Management, before moving on to become a Journal Publishing Manager and then a Publisher in Editorial, and then moving into business development in a Business Innovations group. He has considerable experience in digital product development in a publishing environment, and in working with corporate clients, particularly in the Pharma industry. He now works in the Society Services Team and is responsible for working with societies to generate more revenue from industry, principally through their publications. This includes looking at new content-driven products and services for corporate clients, as well as making sure that the partnerships that we facilitate between industry and societies promote and strengthen the brand of the journal and society and provide value to the end users. He believes that sustainable corporate revenues can only be attained if the primary driver is not money, but value to the society member or journal reader.

Steve Smith

Director
iS Health Group


Siobhan Southam

Global Publications Manager
AstraZeneca


Bio: Siobhan is an experienced global communications and medical affairs professional and is currently leading activities for a number of respiratory programmes. Siobhan's role is to develop communication and publication strategies to communicate science, medicines and health in a meaningful way to all audiences. Siobhan has a broad range and depth of experience across respiratory, inflammation, neuroscience, oncology and infection. Prior to her current role, Siobhan was responsible for a product in late stage development for gout and successfully led the scientific communications as well as an innovative project engaging with patients. Siobhan has a broad range and depth of experience across respiratory, inflammation, neuroscience, oncology and infection gained in communications, pharmaceutical industry and research environments. Siobhan graduated from Leeds University with a BSc in Microbiology and has post-graduate diplomas in marketing and neurolinguistic programming.

Stuart Spencer

Sr. Executive Editor
The Lancet


Bio: Stuart joined The Lancet in 1999 and throughout his time there has led the Fast Track team that aims to select, review and publish prestigious manuscripts within 4 weeks of receipt. Although dealing with all areas of research, he deals with most of the cardiology submissions. After graduating Stuart moved into research which started at the Brompton Hospital, London, looking at scoliosis in children before moving to the Veterinary School site at Bristol University. During this period he was invited to establish a research unit in The Netherlands. Later he set up a research team for a major pharmaceutical company in Switzerland for a year, and then spent 9 years as a senior researcher in New Zealand. He has also had two senior research fellowships at Leuven University, Belgium, and visiting professorships at Kings College, London and Hong Kong University, and a doctorate of medicine from Umea University, Sweden. Stuarts research expertise includes such diverse topics as, growth, neuroendocrinology, immunology and fetal development . He also had a Senior Fellowship in bioethics for 5 years. This broad research base in front-line research has given a clear understanding of principles in research and publications applicable across disciplines. Stuart is also a Trustee of the Scoliosis Association (UK), is on the British Scoliosis Research Fund grants committee and the Steering Committee of the Swedish National GP Research School.

Richard Stephens

Editor-in-Chief
BioMed Central


Bio: Richard is a survivor of two cancers, a heart emergency and sundry other health challenges. He has acted as a carer for family members with both mental health and physical problems. Richard's interest in research comes from his own experiences as a patient, and as a participant in four clinical trials and eleven other research studies. He is the joint Editor-in-Chief of BMC's Journal of Research Involvement and Engagement, in some ways a natural extension from his secondary career as a freelance journalist (mostly sports) and author (mostly local history). His main professional life was spent in education and in local government, but Richard is now a full-time patient advocate in research, driven by a desire to make sure that research outcomes benefit patients, and that the process of participating is made as easy as possible so that patients can help bring benefits to other patients. He Chairs the (UK) National Cancer Research Institute's Consumer Forum and serves with several other international and national committees and bodies, such as EORTC, Eupati, MRC CTU, Genomics England and CRUK. His roles include advisory, funding, and priority-setting work. When time allows, Richard engages in a battle of wills with a gym treadmill, and enjoys sleeping.

Myint Tin Tin Htar

Director, Global Clinical Epidemiology
Pfizer France


Bio: Tin Tin is a medical doctor with post-graduate trainings on public health, epidemiology and vaccinology. She joined vaccine industry in 2006 and worked for medical affairs Sanofi-Pasteur MSD and Pfizer for over 10 years and is currently director at Global Clinical Epidemiology department at Pfizer Vaccines. She was involved in rotavirus and pneumococcal vaccines post-licensure activities. She is also a member of ADVANCE, public-private collaboration for Accelerated development of vaccine benefit-risk collaboration in Europe. Main areas of interest are vaccine preventable diseases, observational studies, infectious disease surveillance, vaccine policy, private-public partnership.